THE DEAL, AT A GLANCE
2/4 reviewedEvvy
.jpg)
Evvy
Evvy sells at-home vaginal microbiome tests with clinician-reviewed results and personalized care plans.
Evvy raised $40M Series B, announced 2026-09-1501What it doesEvvy sells at-home vaginal microbiome tests with clinician-reviewed results and personalized care plans.Source-grounded · automated review · Explore ↗
Checked 2026-10-07 · Review due 2026-10-14
Read supporting source ↗Our at-home vaginal microbiome test…
02What happenedEvvy raised $40M Series B, announced 2026-09-15From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersThe service links vaginal bacteria and fungi testing to care for symptoms, fertility and menopause.Source-grounded · automated review · Explore ↗
Checked 2026-10-07 · Review due 2026-10-14
Read supporting source ↗Evvy offers the most comprehensive…
Click a part to explore its evidence. The image is supplied by the cited source.Original record source ↗
Evvy · Financing Record
Explore source-linked visual explanations for Evvy. Unsupported claims are withheld while source review continues.
Record 12341 · Recorded date: 2026-09-15
Explore company records →